Concepedia

Pratap Neelakantan

PN

Statistics

Publications

8

Citations

258

H-Index

8

Active since

2012

Affiliations

Royal Berkshire NHS Foundation Trust(Current)

Imperial College London

Hammersmith Hospital

Cambridge University Hospitals NHS Foundation Trust

University of Liverpool

Pratap Neelakantan is an author at Royal Berkshire NHS Foundation Trust specializing in immunology, medicine, and platelet activation.

Top concepts

Publications per year

2012–2024

8

Publications

8

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

Pratap Neelakantan, Gareth Gerrard, Claire Lucas et al. · Blood · 2013 · 93 citations · Full text

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Pratap Neelakantan, David Marín, Michael Laffan et al. · Haematologica · 2012 · 37 citations · Full text

, , +16

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study

Dragana Milojković, Nicholas C.P. Cross, Sahra Ali et al. · British Journal of Haematology · 2020 · 29 citations · Full text

Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy

Stephen Booth, John Willan, Dalia Khan et al. · European Journal Of Haematology · 2020 · 28 citations · Full text

Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma

David Austin, Rebecca Maier, Nasima Akhter et al. · JACC CardioOncology · 2024 · 26 citations · Full text

1–5 of 8